January 10, 2022--A study of smokers found that the first day of a quit attempt is more challenging for women than men in 12 low- and middle-income countries, where around 60 percent of the world’s smokers live. Researchers at Columbia University Mailman School of Public Health reported this is a particularly significant finding as the first day of abstinence is one of the most critical predictors of long-term smoking cessation. The study also showed that larger health warning labels on cigarette packs were associated with reduced odds of one-day relapse among women.
Until this research, little was known about sex differences in the very early abstinence period among people who smoked, particularly in the context of low- and middle countries. The findings are published online in the journal Addictive Behaviors.
“A successful first day of abstinence is one of the most important predictors for prolonged smoking cessation, and little is known about why women may find this period more challenging than men,” said João Mauricio Castaldelli-Maia, MD, PhD, NIDA-INVEST Postdoctoral Fellow in the Department of Epidemiology at Columbia Mailman School, and first author. “It may be that withdrawal syndrome, which typically presents on the first day of abstinence and is cited by smokers as the main reason for relapse, may play an essential role in one-day quit attempt outcomes among women who typically report more withdrawal symptoms than men.”
Women also have more difficulty maintaining long-term abstinence than men. Furthermore, the drivers for smoking initiation and cessation differ between men and women. For example, women are more likely to name weight control as a reason to start smoking, but women are also more likely to be motived by health concerns, particularly pregnancy, to attempt to quit smoking compared to men.
The researchers analyzed data from the Global Adult Tobacco Survey (2008-2012), capturing nationally representative samples from the 12 low- and middle-income countries of Bangladesh, Brazil, China, Egypt, India, Indonesia, Mexico, Russia, Thailand, Turkey, Ukraine, and Vietnam that reported smokers with one or more quit attempts in the past 12 months. They also adjusted for various individual level demographics including education, age at smoking initiation and smoking cessation variables. Final analyses were based on a total sample of 16,576 individuals.
Overall reports of one-day relapses ranged from 3 percent to 14 percent. The prevalence of women reporting at least one quit attempt varied considerably across countries—from slightly over one percent in Egypt to 43 percent in Brazil.
With regard to warning labels, prominently sized cautions were associated with reduced odds of one-day relapse among women. Health warning labels on cigarette packs have been shown to effectively reduce tobacco smoking by promoting a greater public understanding of the negative health consequences of smoking.
“Compared to male smokers, women tend to rate graphic warning labels overall as more credible, evoking more negative emotions, and eliciting higher motivation to quit,” noted Silvia Martins, MD, PhD, professor of epidemiology at Columbia Mailman School, and senior author. “Yet, as of 2013, less than half of low-middle income countries included in the Global Adult Tobacco Survey had implemented these warning labels on cigarette boxes.”
Since little research on sex differences in warning label effectiveness has been conducted in low-middle income countries, more inquiry is needed into how interventions can be tailored to address these barriers to sustained abstinence,” according to Castaldelli-Maia and Martins.
“Incorporating national policies, in addition to counseling and pharmacotherapy, could play an essential role in supporting women during the initial abstinence phase of smoking cessation in low- and middle-income countries,” said Castaldelli-Maia. “Medication and/or psychotherapy may be critical in increasing the chance of successfully quitting smoking especially because studies in high-income countries showed that women tend to receive less pharmacological treatment even though they seek treatment more often.”
Co-authors are Elizabeth Nesoff, University of Pennsylvania Perelman School of Medicine; Danielle Lima, Medical School, University of São Paulo (USP); and Zila Sanchez, Medical School, Universidade Federal de São Paulo (UNIFESP).
Columbia University Mailman School of Public Health
Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the fourth largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master’s and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu.